InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the detailed record of transactions filed by Coleman Kirk Allen. Director active across 1 company, notably TFF Pharmaceuticals, Inc.. Cumulatively, 5 reports have been logged. Breakdown: 4 buys · 0 sell. Total volume traded: €25k. Activity tracked since 16 September 2021. The latest transaction was filed on 3 July 2024 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 条申报中的 5 条
COLEMAN KIRK ALLEN is Chief Financial Officer at TFF Pharmaceuticals, Inc. (XNAS). He has 6 filings in total, and in the sampled recent filings the transactions are acquisitions, with buys of EUR 31196 between 2021-09-16 and 2024-07-08 and no sales.